Skip to main content
Log in

Scale for Ocular Motor Disorders in Ataxia (SODA) in Patients with Multiple System Atrophy

  • Research
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

A clinical scale fully dedicated to evaluating ocular motor abnormalities is required for now. We investigated the utility of a recently developed Scale for Ocular motor Disorders in Ataxia (SODA) in patients with multiple system atrophy (MSA). We prospectively assessed SODA in consecutive patients with MSA between August 2021 and August 2023 at the Korea University Medical Center. The results of the clinical exam-based SODA were compared with those measured using video-oculography (VOG-guided SODA). We also compared the findings with other established clinical scales targeting patients with MSA, including the Unified Multiple System Atrophy Rating Scale (UMSARS) I-II, Movement Disorder Society-Unified Parkinson’s Disease Rating Scale motor part (UPDRS-III), Scale for Assessment of Rating of Ataxia (SARA), Composite Autonomic Symptom Score-31 (COMPASS-31), and Composite Autonomic Severity Score (CASS). Twenty patients were enrolled in our study (17 with cerebellar-type MSA and three with Parkinson-type MSA). Scores ranged from 1 to 14 (median [interquartile range (IQR)] = 8 [5−10]). Among the subscales, saccades had a median score of 2.5 (IQR = 1–3), followed by ocular pursuit (1 [0–1]), nystagmus (1 [0–2]), saccadic intrusions (1 [0–1]), vestibulo-ocular reflex (VOR) (0.5 [0–1]), ocular alignment (0 [0–1]), and VOR cancellation (1 [0–1]). The clinical-exam-based SODA (p = 0.020) and VOG-guided SODA (p = 0.034) positively correlated with disease duration. No correlation was found between clinical exam-based SODA and other scales. Skew deviation, gaze-evoked nystagmus, VOR cancellation, and smooth pursuit had the highest precision among the items. Ocular misalignment and spontaneous and positional nystagmus were frequently false positive and were poorly detected with clinical exam-based SODA. Six patients with repeated evaluation exhibited higher scores, along with deterioration documented on other clinical scales. The SODA can reliably predict neurodegeneration as an additional clinical surrogate in MSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Anonymized data will be shared by request from any qualified investigator.

References

  1. Gai W, Power J, Blumbergs P, Blessing W. Multiple-system atrophy: a new α-synuclein disease? Lancet. 1998;352:547–8.

    Article  CAS  PubMed  Google Scholar 

  2. Koga S, Aoki N, Uitti RJ, Van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85:404–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel J-P. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997;54:937–44.

    Article  CAS  PubMed  Google Scholar 

  4. Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL. Improving diagnostic accuracy of Multiple System Atrophy: a clinicopathological study. Brain. 2019;142:2813–27.

    Article  PubMed  Google Scholar 

  5. Kim HJ, Stamelou M, Jeon B. Multiple system atrophy-mimicking conditions: diagnostic challenges. Parkinsonism Relat Disord. 2016;22:12–S15.

    Article  Google Scholar 

  6. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, Ghorayeb I, Ory F, Galitzky M, Scaravilli T. Development and validation of the unified Multiple System Atrophy rating scale (UMSARS). Mov Disord. 2004;19:1391–402.

    Article  PubMed  Google Scholar 

  7. Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Mov Disord. 2009;24:1820–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Shaikh AG, Kim J-S, Froment C, Koo YJ, Dupre N, Hadjivassiliou M, Honnorat J, Kothari S, Mitoma H, Rodrigue X. Scale for Ocular Motor Disorders in Ataxia (SODA): Procedures and Basic Understanding. 347–361. In: Trials for Cerebellar Ataxias: From Cellular Models to Human Therapies. Springer-Verlag: Berlin Heidelberg; 2023.

  9. Shaikh AG, Kim J-S, Froment C, Koo YJ, Dupre N, Hadjivassiliou M, Honnorat J, Kothari S, Mitoma H, Rodrigue X. Scale for Ocular motor Disorders in Ataxia (SODA). J Neurol Sci. 2022;443120472.

  10. Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D. The movement disorder society criteria for the diagnosis of Multiple System Atrophy. Mov Disord. 2022;37:1131–48.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kim JG, Kim SH, Lee SU, Lee CN, Kim BJ, Kim JS, Park KW. Head-impulse tests aid in differentiation of multiple system atrophy from Parkinson’s disease. J Neurol. 2022;269:2972–9.

    Article  PubMed  Google Scholar 

  12. Kim SH, Lee SU, Cho BH, Cho KH, Yu S, Kim BJ, Kim JS. Analyses of head-impulse tests in patients with posterior circulation stroke and vestibular neuritis. Neurology. 2023;100:e2374–85.

    Article  CAS  PubMed  Google Scholar 

  13. Scheiman M, Wick B. Clinical management of binocular vision: heterophoric, accommodative, and eye movement disorders. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  14. Schmitz-Hübsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.

    Article  PubMed  Google Scholar 

  15. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R. Movement Disorder Society‐sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.

    Article  PubMed  Google Scholar 

  16. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196–201.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc. 1993;68:748–52.

    Article  CAS  PubMed  Google Scholar 

  18. Kim JB, Kim H, Sung JH, Baek SH, Kim BJ. Heart-rate-based machine-learning algorithms for screening orthostatic hypotension. J Clin Neurol. 2020;16:448–54.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kim JG, Lee JH, Lee SU, Choi JY, Kim BJ, Kim JS. Utricular dysfunction in patients with orthostatic hypotension. Clin Aut Res. 2022;32:431–44.

    Article  Google Scholar 

  20. Sarva H, Shanker VL. Treatment options in degenerative cerebellar ataxia: a systematic review. Mov Didsord Clin Pract. 2014;1:291–8.

    Article  Google Scholar 

  21. Maaß S, Levin J, Höglinger G. Current treatment of multiple system atrophy. Curr Curr Treat Options Neurol. 2016;18:51.

    Article  PubMed  Google Scholar 

  22. Young AS, Rosengren SM, D’Souza M, Bradshaw AP, Welgampola MS. Nystagmus characteristics of healthy controls. J Vestib Res. 2020;30:345–52.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Martens C, Goplen FK, Nordfalk KF, Aasen T, Nordahl SHG. Prevalence and characteristics of positional nystagmus in normal subjects. Otolaryngol Head Neck Surg. 2016;154:861–7.

    Article  PubMed  Google Scholar 

  24. Choi JY, Kim JH, Kim HJ, Glasauer S, Kim JS. Central paroxysmal positional nystagmus: characteristics and possible mechanisms. Neurology. 2015;84:2238–46.

    Article  PubMed  Google Scholar 

  25. Choi JY, Glasauer S, Kim JH, Zee DS, Kim JS. Characteristics and mechanism of apogeotropic central positional nystagmus. Brain. 2018;141:762–75.

    Article  PubMed  Google Scholar 

  26. Shin JH, Shin DA, Lee CY, Chang HJ, Woo KA, Kim HJ, Lee JC, Jeon B. Inability to suppress head rotation during the saccade test as a clinical biomarker for cognitive dysfunction in Parkinson’s disease. Neurosci Lett. 2023;812:137356.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Basic Research Program through the National Research Foundation of Korea (NRF), funded by the MSIT (2022R1A4A1018869).

Author information

Authors and Affiliations

Authors

Contributions

Dr. H. Yoon analyzed and interpreted the data and wrote the manuscript.Drs. H. Kwon, E. Park, C.N. Lee, B.J. Kim, J.S. Kim, and K.W. Park analyzed and interpreted the data, and revised the manuscript.Dr. S.U. Lee designed and conceptualized the study, interpreted the data, and revised the manuscript.

Corresponding author

Correspondence to Sun-Uk Lee.

Ethics declarations

Ethical Approval

This study followed the tenets of the Declaration of Helsinki and was performed according to the guidelines of the Institutional Review Board of Korea University Anam Hospital (2021AN0173).

Competing Interests

Drs. H. Yoon, H. Kwon, E. Park, S.U. Lee, C.N. Lee, and K.W. Park report no disclosures. BJ Kim serves as an Editor-in-Chief of the Journal of Clinical Neurology. JS Kim serves as an Associate Editor of Frontiers in Neuro-otology and on the editorial boards of the Journal of Clinical Neurology, Frontiers in Neuro-ophthalmology, Journal of Neuro-ophthalmology, Journal of Vestibular Research, Medicine, and Clinical and Translational Neuroscience.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoon, H., Kwon, H., Lee, SU. et al. Scale for Ocular Motor Disorders in Ataxia (SODA) in Patients with Multiple System Atrophy. Cerebellum (2023). https://doi.org/10.1007/s12311-023-01653-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12311-023-01653-y

Keywords

Navigation